A qualitative study examining the perception and governance of emerging neurotechnologies in Latin America has found that while Argentina and Mexico maintain strong neuroscience traditions, the development and deployment of neurotechnologies remain constrained, uneven, and largely concentrated within a small number of institutions. Reporting in BMC Medical Ethics, researchers Laura Y. Cabrera and Arleen Salles analyzed expert insights to demonstrate how broader socio-political environments, regulatory uncertainty, and long-standing structural barriers impede the equitable advancement and translation of neurotechnological tools in both countries.
The authors contextualized their study within the broader social and historical landscape of Latin America, emphasizing that the region is defined by deep cultural diversity and complex social dynamics. Distinct subcultures across the continent have been formed by Indigenous, Afro-Caribbean, and European influences, resulting in traditions, belief systems, and social structures that vary substantially between different countries and ethnic populations. Despite this diversity, many Latin American nations share common historical trajectories shaped by colonial legacies, uneven development, and persistent structural inequalities. According to the study, these shared histories have produced contemporary challenges across the region, including socioeconomic disadvantage, political and economic instability, and corruption, which collectively frame how emerging scientific capabilities such as neurotechnologies are interpreted, received, and governed.
To examine how these conditions operate in scientific practice, the researchers selected Argentina and Mexico as comparative case studies. Both nations exhibit strong macroeconomic indicators relative to many of their regional neighbors and represent major contributors to scientific advancement in the region. Specifically, both Argentina and Mexico have established strong neuroscience traditions supported by high-profile, internationally recognized neuroscience research centers, making them prime environments for assessing the current status and governance of regional neurotechnology.
The empirical foundation of the study rested on qualitative data gathered from four mini-focus groups conducted with regional specialists. The researchers assembled two focus groups consisting of Mexican experts, comprising nine participants in total, and two focus groups composed of Argentinian experts, comprising seven participants, yielding a combined study cohort of sixteen experts. To evaluate the discussions, the authors applied qualitative thematic content analysis, systematically organizing and coding the focus group transcripts to map recurring themes, draw direct comparisons, and isolate both shared viewpoints and country-specific differences.
The investigation revealed that despite their scientific reputations and institutional capacity, both nations face severe hurdles that hinder the practical deployment of neurotechnologies. Participants in both Argentina and Mexico pointed to regulatory uncertainty and chronic underinvestment in science and technology as major structural barriers. Experts also identified limited interdisciplinary collaboration and pronounced regional disparities in access as ongoing obstacles that restrict neurotechnological applications to a limited number of elite institutions.
Alongside these shared structural barriers, the focus groups uncovered pronounced differences rooted in each country’s distinct sociocultural setting. In the Mexican focus groups, participants placed particular emphasis on a lack of capacity building, insufficient dissemination of scientific knowledge, and a continuing dependence on technological innovations imported from the Global North. By contrast, the discussions among Argentinian experts underscored the enduring influence of psychoanalysis, which heavily shapes how neuroscience and neurotechnologies are conceptualized, accepted, and implemented in clinical and academic settings. In addition, Argentinian participants raised explicit ethical concerns regarding the dual-use potential of neurotechnology.
In their conclusions, Cabrera and Salles stressed that while Argentina and Mexico operate within their own distinct regulatory frameworks and sociocultural landscapes, they exhibit fundamental commonalities in the challenges confronting neurotechnology innovation. The researchers emphasized that advancing responsible neurotechnology will require a deeper understanding of the specific socio-political factors that govern regional perspectives. Moving forward, the authors highlighted the necessity of fostering more effective public dissemination and establishing robust interdisciplinary collaboration to overcome regional disparities and ensure that neurotechnological development aligns with local needs.
Subject of Research: Expert perspectives on neurotechnology governance and development in Argentina and Mexico
Article Title: Responsible neurotechnology in context: Insights from focus groups in Argentina and Mexico
Article References: Cabrera, L. Y., & Salles, A. (2026). Responsible neurotechnology in context: Insights from focus groups in Argentina and Mexico. BMC Medical Ethics. https://doi.org/10.1186/s12910-026-01630-0
Image Credits: AI Generated
DOI: 10.1186/s12910-026-01630-0
Keywords: neurotechnology, bioethics, Argentina, Mexico, neuroscience, science policy, qualitative research, Latin America, Responsible, context, Insights, focus
News Source: Courtney Benton. (November 11, 2026). Focus Groups Highlight Uneven Neurotechnology Progress in Argentina and Mexico. Scienmag.



